We understand that people with cancer are worried about coronavirus. Here is the latest guidance. We will update it regularly.

Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 251

Cover image of 'POEMS syndrome'

POEMS syndrome (March 2019)

Myeloma UK

POEMS syndrome is a rare disorder that can affect multiple systems in the body. It is named after five common features of the syndrome: polyneuropathy (also known as peripheral neuropathy); organomegaly (enlargement of organs, such as the liver, spleen or lymph nodes); endocrinopathy (abnormal function of endocrine glands); monoclonal plasma cell disorder; and skin changes. This factsheet explains what POEMS syndrome is, how it is diagnosed and how it is treated and managed.

Cover image of 'Donor (allogeneic) stem cell transplants'

Donor (allogeneic) stem cell transplants (July 2019)

Lymphoma Action

This information is about allogeneic (donor) stem cell transplants for people with lymphoma. It explains what a donor (allogeneic) stem cell transplant is, who might have one, what is involved, the risks and what happens afterwards?

Cover image of 'Hepatosplenic T-cell lymphoma'

Hepatosplenic T-cell lymphoma (August 2019)

Lymphoma Action

Hepatosplenic T-cell lymphoma is a rare type of lymphoma that affects the liver and spleen. This factsheet covers the following topics: What is hepatosplenic T-cell lymphoma?; Who gets it?; Symptoms; Treatment; Relapsed or refractory hepatosplenic T-cell lymphoma; Research and targeted treatments.

Cover image of 'Lymphoplasmacytic lymphoma and Waldenström’s macroglobulinaemia'

Lymphoplasmacytic lymphoma and Waldenström’s macroglobulinaemia (August 2019)

Lymphoma Action

Lymphoplasmacytic lymphoma (LPL) is a rare type of non-Hodgkin lymphoma. Waldenström’s macroglobulinaemia (WM) is the most common type of LPL. This page covers the following topics: What are lymphoplasmacytic lymphoma and Waldenström’s macroglobulinaemia?; Who might get Waldenström’s macroglobulinaemia?; Symptoms; Diagnosis; Treatment; Outlook; Relapse; Follow-up; Research and clinical trials.

Cover image of 'Antibody therapy for lymphoma (including rituximab)'

Antibody therapy for lymphoma (including rituximab) (February 2019)

Lymphoma Action

This factsheet explains what antibody therapy is and how it is used to treat lymphoma.

Cover image of 'Relationships, family, friends'

Relationships, family, friends (July 2019)

Lymphoma Action

This factsheet describes some of the ways lymphoma might affect your relationships. It covers: The impact of lymphoma on relationships; You and your partner; Friends, colleagues and acquaintances; Connecting with others who are affected by lymphoma.

Cover image of 'Burkitt lymphoma'

Burkitt lymphoma (April 2019)


Burkitt lymphoma is a fast-growing form of blood cancer that can affect adults and children. This fact sheet explains what Burkitt lymphoma is, how it’s diagnosed and treated in adults, and where to go for more support. 

Cover image of 'Complementary therapy'

Complementary therapy (June 2019)

Lymphoma Action

This factsheet describes complementary therapies and how they may be used in lymphoma. It has brief information about the different types (acupuncture, aromatherapy, art therapy, chiropractic care, massage, mindfulness, music therapy, tai chi and yoga), and also looks at choosing a complementary therapy, finding a practitioner, the availability of complementary therapy and regulation.

Cover image of 'Growth factors'

Growth factors (February 2019)

Lymphoma Action

This factsheet is about blood cell growth factors, specifically granulocyte-colony stimulating factor (G-CSF), which may be given as part of treatment for lymphoma. It explains what growth factors are, when they can be used, how they are given, and possible side effects.

Cover image of 'Maintenance therapy (including rituximab maintenance)'

Maintenance therapy (including rituximab maintenance) (February 2019)

Lymphoma Action

This factsheet describes maintenance therapy, used to prolong remission after successful treatment of lymphoma. It explains what it is, whio can have it and the risks and benefits.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm